You are here: Industry Insights > innovative drug

News List

EQRx, known as the "TEMU" of the Pharmaceutical Industry, has been Acquired by Revolution Medicines PharmaSources/Xiaobing
August 15, 2023
EQRx, known as the "TEMU" of the pharmaceutical industry, has been acquired by Revolution Medicines，posing a risk of "returns" for Chinese innovative drugs.
A New Record of the New Chinese Medicine Approval with the Review & Approval Systems Reform of the Traditional Chinese Medicine PharmaSources/Zhulikou431
January 13, 2022
The Chinese civilization has been in existence for over five thousand years, and the traditional Chinese medicine is one of the most crucial treasure, which embodies the vast wisdom of the Chinese people and the Chinese nation.
Mobocertinib succinate capsules approved for marketing with conditions www.nmpa.com
January 11, 2023
Mobocertinib succinate capsules approved for marketing with conditions.
Arthrosi Establishes Joint Venture in China to Accelerate Development of Innovative Drug Portfolio firstwordpharma
August 18, 2021
Arthrosi Therapeutics, Inc. today announced a joint venture in Guangzhou, China with Guangzhou Ruiao Biopharmaceutical Technology Co., Ltd. ("a subsidiary of ApicHope Phamaceutical") to form Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd.
Speeding up review and guaranteeing payments: Blockbuster innovative drugs becoming truly accessible in China En-CPhI.CN
January 14, 2020
The negotiated national reimbursement drug list (NRDL) of China in 2019 was issued on Nov. 28, 2019 as scheduled!
China’s First Innovative Drug for Alzheimer’s Disease: GV-971 Marketed at RMB895 PharmaSources/Dishui Sinan
January 06, 2020
The innovative drug for Alzheimer’s disease (AD)-GV-971 (sodium oligomannurarate) has been officially marketed in China, which is priced at RMB895/box and has attracted much attention of the pharmaceutical practitioners.
Mainstream psoriasis drugs marketed in the world PharmaSources/Caicai
July 10, 2019
Marketing of benvitimod, a Chinese-produced Class 1 innovative drug
HitGen and Mitsubishi Tanabe Pharma Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration pharmafocusasia
December 11, 2018
HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Mitsubishi Tanabe Pharma Corporation....
Herantis Pharma Plc publishes introductory video on its Lymfactin with the leading lymphedema advoca firstwordpharma
January 24, 2017
Herantis Pharma Plc ("Herantis") has published an introductory video explaining the mechanism of its innovative drug candidate Lymfactin®, which it develops as a disease modifying treatment for lymphedema.